Back to Alerts
Healthcare•10d ago

RARE Maintained by Cantor Fitzgerald -- Price Target Lowered to $33

RARE Maintained by Cantor Fitzgerald -- Price Target Lowered to $33

On October 03, 2023, the analyst rating for Ultragenyx Pharmaceutical Inc (RARE) was maintained as Overweight by Cantor Fitzgerald. The price target has been si

GuruFocus
Article
News
GuruFocus News
RARE
Source: gurufocus.com

Sponsored

Sponsored

Master the Millennial Market mindset

Learn advanced portfolio strategies for 2024

Market Sectors

Blogs12

Markets8

Subscribers15

Related Alerts

3 Reports
RARE Maintained by Wedbush -- Price Target Lowered to $23.00Healthcare
Source: gurufocus.com10d ago

RARE Maintained by Wedbush -- Price Target Lowered to $23.00

Ultragenyx Pharmaceutical (RARE) Analyst Rating Update On October 5, 2023, Wedbush maintained a Neutral rating on Ultragenyx Pharmaceutical Inc (RARE). The f

Verified Marketplace IntelligenceREAD REPORT
RARE Maintained by Canaccord Genuity -- Price Target Lowered to $37.00Healthcare
Source: gurufocus.com10d ago

RARE Maintained by Canaccord Genuity -- Price Target Lowered to $37.00

Ultragenyx Pharmaceutical (RARE) Analyst Rating Update On September 3, 2026, Canaccord Genuity analyst Whitney Ijem maintained a Buy rating on Ultragenyx Pha

Verified Marketplace IntelligenceREAD REPORT
RARE Downgraded by Baird -- Price Target Lowered to $16.00Healthcare
Source: gurufocus.com10d ago

RARE Downgraded by Baird -- Price Target Lowered to $16.00

Ultragenyx Pharmaceutical Inc (RARE) Analyst Rating Update On October 03, 2023, Ultragenyx Pharmaceutical (RARE) was downgraded by Baird analyst Joel Beatty

Verified Marketplace IntelligenceREAD REPORT